These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8645989

  • 1. Specific high affinity binding of platelet activating factor to intact human blood neutrophils and eosinophils.
    Korth RM.
    Int Arch Allergy Immunol; 1996 Jun; 110(2):124-31. PubMed ID: 8645989
    [Abstract] [Full Text] [Related]

  • 2. Specific binding sites for 1-O-alkyl-sn-glyceryl-3-phosphorylcholine on intact human blood neutrophils.
    Korth RM.
    Int Arch Allergy Immunol; 1997 Aug; 113(4):460-4. PubMed ID: 9250592
    [Abstract] [Full Text] [Related]

  • 3. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [Abstract] [Full Text] [Related]

  • 4. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
    Ukena D, Dent G, Chanez P, Barnes PJ, Sybrecht GW.
    Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
    Paulson SK, Wolf JL, Novotney-Barry A, Cox CP.
    Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
    [Abstract] [Full Text] [Related]

  • 6. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
    Zhou W, Javors MA, Olson MS.
    Arch Biochem Biophys; 1994 Feb 01; 308(2):439-45. PubMed ID: 8109973
    [Abstract] [Full Text] [Related]

  • 7. Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes.
    Herbert JM, Laplace MC, Maffrand JP.
    Biochem Pharmacol; 1993 Jan 07; 45(1):51-8. PubMed ID: 8381007
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K, Wardlaw AJ, Moqbel R, Kay AB.
    J Allergy Clin Immunol; 1989 Jan 07; 83(1):83-90. PubMed ID: 2536413
    [Abstract] [Full Text] [Related]

  • 9. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar 07; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
    Sanz MJ, Weg VB, Walsh DT, Williams TJ, Nourshargh S.
    Br J Pharmacol; 1994 Oct 07; 113(2):513-21. PubMed ID: 7834203
    [Abstract] [Full Text] [Related]

  • 11. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
    Kudolo GB, Harper MJ.
    Biol Reprod; 1989 Oct 07; 41(4):587-603. PubMed ID: 2559778
    [Abstract] [Full Text] [Related]

  • 12. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
    Herbert JM, Laplace MC, Cailleau C, Maffrand JP.
    J Lipid Mediat; 1993 May 07; 7(1):57-78. PubMed ID: 8395255
    [Abstract] [Full Text] [Related]

  • 13. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 07; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 14. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.
    Svetlov S, Nigam S.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):162-6. PubMed ID: 8380690
    [Abstract] [Full Text] [Related]

  • 15. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L, Zuurbier AE, Mul FP, Verhoeven AJ, Lutter R, Knol EF, Roos D.
    J Immunol; 1998 Sep 15; 161(6):3064-70. PubMed ID: 9743372
    [Abstract] [Full Text] [Related]

  • 16. A mechanism for phorbol ester-mediated regulation of the PAF receptor in human neutrophils.
    Zhou W, Olson MS.
    Arch Biochem Biophys; 1994 Aug 15; 313(1):179-83. PubMed ID: 8053680
    [Abstract] [Full Text] [Related]

  • 17. PAF receptors and G-proteins in human blood eosinophils and neutrophils.
    Agrawal DK, Ali N, Numao T.
    J Lipid Mediat; 1992 Aug 15; 5(2):101-4. PubMed ID: 1326343
    [Abstract] [Full Text] [Related]

  • 18. Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation.
    Kroegel C, Giembycz MA, Matthys H, Westwick J, Barnes PJ.
    Am J Respir Cell Mol Biol; 1994 Nov 15; 11(5):593-9. PubMed ID: 7946388
    [Abstract] [Full Text] [Related]

  • 19. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.
    Herbert JM.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.
    Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y.
    J Immunol; 1989 Aug 15; 143(4):1295-302. PubMed ID: 2545786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.